# ALNYLAM PHARMACEUTICALS, INC. (ALNY) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ALNYLAM PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ALNY/mda/fy2025/): filed 2026-02-12; accession 0001628280-26-007497 (https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ALNY/mda/fy2024/): filed 2025-02-13; accession 0001178670-25-000026 (https://www.sec.gov/Archives/edgar/data/1178670/000117867025000026/alny-20241231.htm)
- [FY 2023 MD&A](/company/ALNY/mda/fy2023/): filed 2024-02-15; accession 0001178670-24-000008 (https://www.sec.gov/Archives/edgar/data/1178670/000117867024000008/alny-20231231.htm)
- [FY 2022 MD&A](/company/ALNY/mda/fy2022/): filed 2023-02-23; accession 0001178670-23-000005 (https://www.sec.gov/Archives/edgar/data/1178670/000117867023000005/alny-20221231.htm)
- [FY 2021 MD&A](/company/ALNY/mda/fy2021/): filed 2022-02-10; accession 0001178670-22-000013 (https://www.sec.gov/Archives/edgar/data/1178670/000117867022000013/alny-20211231.htm)

Back to /company/ALNY/